Agios Pharma (AGIO) Tops Q1 EPS by 12c

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.69), $0.12 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $13.91 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Veeva Systems (VEEV) Tops Q1 EPS by 10c, Offers Guidance
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours